Results for “ ”

Entry Author Date Location
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
In Microbiome Milestone, Finch Therapeutics C. diff Pill Bests Placebo 06/19/20 Boston
Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs 06/18/20 San Diego
Orca Bio Surfaces With $192M and Recipes for “Custom” Cell Therapies 06/17/20 San Francisco
Frazier Launches Lassen to Advance Antibodies Against Fibrosis, Cancer 06/17/20 San Diego
C4 Therapeutics Adds $170M to Test Protein Degraders in the Clinic 06/16/20 Boston
GSK Expands Synthetic Lethality Scope With $120M Ideaya Bio Alliance 06/16/20 San Francisco
Akili Interactive’s Video Game for ADHD Gets the FDA All Clear 06/15/20 Boston
FDA Reverses Authorization for Use of Antimalarials to Treat COVID-19 06/15/20 National
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track 06/12/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia 06/11/20 Boston
Moderna Finalizes Plan, Dose for Phase 3 Test of mRNA COVID Vaccine 06/11/20 Boston
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition 06/09/20 New York
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain” 06/09/20 Boston
Sarepta Eyes Key Test for Gene Therapy in Rare Muscular Dystrophy 06/08/20 Boston
Akouos Aims for an IPO to Advance Hearing Loss Gene Therapy to Clinic 06/08/20 Boston
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Atlas Venture Raises $400M Fund to Seed Another New Set of Biotechs 06/05/20 Boston
Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline 06/04/20 Boston
Accent, AstraZeneca Ink Cancer Drug Deal to Block RNA-Modifying Proteins 06/04/20 Boston
NodThera Adds $55M to Advance Drugs to Better Regulate Inflammation 06/03/20 Boston
Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact 06/01/20 New York
Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs 05/29/20 Boston
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech 05/27/20 Boston
COVID-19 Sparks New Opportunities for Digital Health Companies 05/26/20 Boston
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Page 2 of 634 « previous page · next page »